PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Genstruct Applying Epistemics Approach To 'Molecular World' (BioWorld Today)
News | 01. 20. 2004
Genstruct Inc. is approaching a drug discovery obstacle in a thoroughly modern way, that is, with what it calls “logical models” of biological systems designed to uncover and define compound mechanisms of action and disease mechanisms.
